News
How Does the Complexity of Obesity Impact the Effectiveness of GLP-1s?
4+ hour, 10+ min ago (298+ words) Phenomix CEO Mark Bagnall discusses the effectiveness of GLP-1s and how obesity impacts different patients in a variety of complex ways. Clearly, the drugs are still popular. However, new data collected by Phenomix and the Mayo Clinic suggests that patients…...
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
4+ hour, 10+ min ago (156+ words) This disconnect between clinical efficacy and real-world utilization remains one of the most persistent challenges in lipid management. Emerging Pharma Leaders nominations are now open! Do you know someone who can make tough decisions that continue to face manufacturers? Are…...
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
13+ hour, 39+ min ago (486+ words) In today's Pharmaceutical Executive Daily, activist investor Shah Capital escalates its campaign against Novavax's board ahead of the company's annual meeting, a Louisiana federal judge declines to block mail-order access to mifepristone while leaving open the possibility of a future…...
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
19+ hour, 21+ min ago (985+ words) Dan Bell, chief strategy officer at Marken, discusses how biopharma companies and logistics teams are responding to the dual disruptors to global supply chain operations. Against the backdrop of already converging geopolitical tensions and regulatory uncertainty, Bell also discusses the…...
Louisiana Federal Judge Rules Against Blocking Sending Abortion Pill Through Mail
17+ hour, 57+ min ago (490+ words) A federal judge declined to block mail prescriptions for the abortion pill mifepristone, at least temporarily, dealing a setback to Louisiana's effort to curtail access to the drug in states where abortion is banned. Emerging Pharma Leaders nominations are now…...
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
19+ hour, 34+ min ago (449+ words) Shah Capital, Novavax's second-largest shareholder, escalated its campaign against the vaccine maker's leadership, announcing plans to vote against board nominees and executive compensation at the company's upcoming annual meeting while stopping short of launching a formal proxy fight. Emerging Pharma…...
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
1+ day, 13+ hour ago (979+ words) Disruptions from the U. S. and Iran conflict moves across key transit routes and threatens the flow of active ingredients, price spikes, and heightened risk of drug shortages worldwide. The ongoing military conflict between the U. S. and Iran affected global pharma supply chains,…...
Pharmaceutical Executive Daily: Wegovy HD Now Available in the U. S.
1+ day, 18+ hour ago (147+ words) In today's Pharmaceutical Executive Daily, Novo Nordisk launches Wegovy HD nationwide across the U. S. , Gilead Sciences agrees to acquire German antibody-drug conjugate biotech Tubulis for up to $5 billion, and Pharmaceutical Executive marks World Health Day 2026 with a collection of voices from…...
Gilead Enters $5 Billion Agreement to Acquire Tubulis
2+ day, 23+ min ago (489+ words) Gilead Sciences" acquisition of Tubulis underscores the intensifying industry focus on antibody-drug conjugates as a key frontier in oncology treatment. Gilead Sciences agreed to acquire Tubulis Gmb H for upwards of $5 billion in a deal that significantly expands Gilead's oncology…...
How Many GLP-1 Users Must Seek Medical Care for Side Effects?
1+ day, 23+ hour ago (277+ words) GLP-1 side effects can be serious, and Phenomix CEO Mark Bagnall discusses the impact they can have on patients, who are not always fully educated. Clearly, the drugs are still popular. However, new data collected by Phenomix and the Mayo…...